Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?

On Friday, Exelixis, Inc. EXEL authorized repurchasing up to an additional $500 million of the company’s common stock before December 31, 2025.Exelixis plans to complete the$500 million stock repurchase program, announced in August 2024, in the second quarter of 2025 and commence stock repurchases under the newly authorized stock repurchase program thereafter.As of the end of fiscal year 2024, Exelixis has returned over $1.2 billion to shareholders through these programs.Earlier this month, Exelixis report ...